The extracellular matrix is an essential component of animal form and as such undergoes extensive modeling during growth and embryonic development. Many of the genes for structural components of the extracellular matrix, and for specific degradative enzymes and their inhibitors, have been identified and cloned. However, much less is known about how expression of these genes is regulated in time and space during embryogenesis and how this may be perturbed by teratogens or congenital abnormalities.
The aim of this proposal is to establish an integrative approach to this complex problem by a) comparing in developing mouse embryos the temporal and spatial patterns of transcription of a number of different matrix associated genes using the techniques of Northern analysis and in situ hybridization. Detailed studies will be made of genes for the metalloproteinase, transin (stromelysin), and the metalloproteinase inhibitor, TIMP, compared with the Ca++-binding proteins Sparc (osteonectin) and 2ar (osteopontin), b) defining the DNA sequences in the mouse Sparc and rat transin genes which control their correct tissue and stage-specific expression during embryogenesis using transgenic mice, and c) studying the way in which the vitamin A derivative, retinoic acid, a low molecular weight morphogen and teratogen with profound effects on proliferation and cell differentiation, regulates extracellular matrix associated gene expression. The model system to be used is the induction of the Sparc gene in mouse F9 teratocarcinoma cells. These proposals will be carried out in the context of other studies on genes regulating embryonic development and the abnormal behavior of cancer cells within the environment of the extracellular matrix.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025580-04
Application #
3326758
Study Section
Special Emphasis Panel (SSS (19))
Project Start
1989-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Matrisian, L M; Gaire, M; Rodgers, W H et al. (1994) Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium. Contrib Nephrol 107:94-100
Rodgers, W H; Osteen, K G; Matrisian, L M et al. (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168:253-60
Matrisian, L M; Ganser, G L; Kerr, L D et al. (1992) Negative regulation of gene expression by TGF-beta. Mol Reprod Dev 32:111-20
Matrisian, L M (1992) The matrix-degrading metalloproteinases. Bioessays 14:455-63
Ganser, G L; Stricklin, G P; Matrisian, L M (1991) EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 35:453-61
Jones, C M; Lyons, K M; Hogan, B L (1991) Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 111:531-42
Zimmerman, E C; Jones, C M; Fet, V et al. (1991) Nucleotide sequence of mouse SCIP cDNA, a POU-domain transcription factor. Nucleic Acids Res 19:956
Matrisian, L M (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-5
Matrisian, L M; Hogan, B L (1990) Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24:219-59
Lyons, K M; Pelton, R W; Hogan, B L (1990) Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109:833-44